A 45-Year-Old With Neuroendocrine Carcinoma of the Prostate
Open Access
- 30 April 2013
- journal article
- case report
- Published by Elsevier BV in Urology
- Vol. 81 (4), 714-716
- https://doi.org/10.1016/j.urology.2012.12.029
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008Prostate Cancer and Prostatic Diseases, 2012
- Small cell neuroendocrine carcinoma of the prostate: Incidence and a report of four cases with an examination of KIT and PDGFRAThe Prostate, 2011
- Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiationMolecular Cancer Therapeutics, 2008
- Clinical implications of neuroendocrine differentiation in prostate cancerProstate Cancer and Prostatic Diseases, 2006
- Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: A case report and short literature reviewUrologic Oncology: Seminars and Original Investigations, 2006
- Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 studyUrology, 2005
- Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory diseaseEndocrine-Related Cancer, 2005